Abstract
The paper presents a novel synthesis of AZT modified derivatives via click chemistry. Firstly, the reaction of 2,4-dihydroxyacetophenone (1) with propargyl bromide in acetone gave intermediates 2 in 75% yield. Next, new chalcones 3a-g were obtained in 55-65% yields through the Claisen-Schmidt reaction of 2 with different aromatic aldehydes. These chalcones were then oxidatively cyclized in DMSO in the presence of I2 to furnish new flavones 4a-g in 45-59% yields. Finally, title compounds 5a-g and 6a-g were obtained via click reaction of 3a-h and 4a-h with 3’-Azido-2’- deoxythymidine (AZT). Novel AZT derivatives 5a-g, 6a-g were evaluated for in vitro cytotoxic activity against five cell lines: MCF-7, SK-LU-1, SW480, HepG2 and P388. The result showed that most of AZT derivatives are active to five cell lines, in which compounds 5g and 5e are found to be the most potent cytotoxic activity against SK-LU-1 and P388 cell lines with IC50 value of 8.63 and 9.05 µg/mL, respectively.
Keywords: AZT, anti-cancer, Click chemistry, Chalcone, Flavone, Triazole.
Letters in Drug Design & Discovery
Title:Triazole-linked Chalcone and Flavone Hybrid Compounds Based on AZT Exhibiting In Vitro Anti-Cancer Activity
Volume: 11 Issue: 3
Author(s): Nguyen Van Minh, Nguyen Le Anh, Do Thi Thao and Tran Khac Vu
Affiliation:
Keywords: AZT, anti-cancer, Click chemistry, Chalcone, Flavone, Triazole.
Abstract: The paper presents a novel synthesis of AZT modified derivatives via click chemistry. Firstly, the reaction of 2,4-dihydroxyacetophenone (1) with propargyl bromide in acetone gave intermediates 2 in 75% yield. Next, new chalcones 3a-g were obtained in 55-65% yields through the Claisen-Schmidt reaction of 2 with different aromatic aldehydes. These chalcones were then oxidatively cyclized in DMSO in the presence of I2 to furnish new flavones 4a-g in 45-59% yields. Finally, title compounds 5a-g and 6a-g were obtained via click reaction of 3a-h and 4a-h with 3’-Azido-2’- deoxythymidine (AZT). Novel AZT derivatives 5a-g, 6a-g were evaluated for in vitro cytotoxic activity against five cell lines: MCF-7, SK-LU-1, SW480, HepG2 and P388. The result showed that most of AZT derivatives are active to five cell lines, in which compounds 5g and 5e are found to be the most potent cytotoxic activity against SK-LU-1 and P388 cell lines with IC50 value of 8.63 and 9.05 µg/mL, respectively.
Export Options
About this article
Cite this article as:
Minh Van Nguyen, Anh Le Nguyen, Thao Thi Do and Vu Khac Tran, Triazole-linked Chalcone and Flavone Hybrid Compounds Based on AZT Exhibiting In Vitro Anti-Cancer Activity, Letters in Drug Design & Discovery 2014; 11 (3) . https://dx.doi.org/10.2174/157018081131000073
DOI https://dx.doi.org/10.2174/157018081131000073 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-cancer Effect of Cyanidin-3-glucoside from Mulberry via Caspase-3 Cleavage and DNA Fragmentation in vitro and in vivo
Anti-Cancer Agents in Medicinal Chemistry Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Selective Histone Deacetylase Inhibitors with Anticancer Activity
Current Topics in Medicinal Chemistry Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Role of Iodine in Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies
Current Pharmaceutical Design Data Tagging in Medical Images: A Survey of the State-of-Art
Current Medical Imaging Intercalators as Anticancer Drugs
Current Pharmaceutical Design Riboregulators and Metabolic Disorders: Getting Closer Towards Understanding the Pathogenesis of Diabetes Mellitus?
Current Molecular Medicine Src Kinase Inhibitors: An Update on Patented Compounds
Current Medicinal Chemistry Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
Current Pharmaceutical Design Formulation and Assessment of In Vivo Anti-Inflammatory Potential of Omega-3-Fatty Acid Loaded Self Emulsifying Nanoemulsion
Current Nanomedicine Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly
Current Pharmaceutical Design 5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β
Anti-Cancer Agents in Medicinal Chemistry Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells
Current Cancer Drug Targets Cancer, Signal Transduction and Nanotechnology
Current Drug Delivery Gene Transfer to the Central Nervous System: Current State of the Art of the Viral Vectors
Current Genomics AMPA Receptor Antagonist CFM-2 Decreases Survivin Expression in Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Exogenous Hormonal Regulation in Breast Cancer Cells by Phytoestrogens and Endocrine Disruptors
Current Medicinal Chemistry Radiation-Induced Pulmonary Epithelial-Mesenchymal Transition: A Review on Targeting Molecular Pathways and Mediators
Current Drug Targets